TABLE 7.
Country (Year of the survey) | Insulin human Soluble/OB | Insulin human soluble/BS | Insulin human isophane/OB | Insulin human isophane/BS | Vial | Prefilled pens | Cartridge |
---|---|---|---|---|---|---|---|
Pakistan (2019) | 1.5 | 1.0 | 1.4 | 1.0 | 1.2 | 5.2 | 2.2 |
Egypt (2013) | 0.8 | 0.8 | 0.8 | 0.8 | - | - | - |
Iran (2014) | 0.4 | 0.4 | - | - | - | ||
Lebanon (2013) | 1.1 | 0.7 | 1.1 | 0.7 | - | - | - |
Nepal (2016) | - | - | - | - | 3.3 | - | 6.9 |
India, Bengaluru (2017) | - | - | - | - | 1.4 | 5.1 | 3.5 |
(-): Data not available.